Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin
在2型糖尿病患者中，从第一代基础胰岛素换用第二代基础胰岛素（甘精胰岛素300 U/mL）与换用其他第一代基础胰岛素相比，其真实世界中的持续性、依从性、医疗资源利用情况和成本如何？
期刊:
影响因子:
doi:10.18553/jmcp.2022.21436
Wright, Eugene E Jr; Malone, Daniel C; Trujillo, Jennifer M; Gill, Jasvinder; Huse, Samuel; Li, Xuan; Zhou, Fang Liz; Preblick, Ron; Reid, Timothy
